Effects of Lutein Supplementation on Oxidative Stress and Inflammation in Healthy Nonsmokers

NCT ID: NCT01056094

Last Updated: 2012-06-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1/PHASE2

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-04-30

Study Completion Date

2012-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Lutein is one of oxygenated carotenoids. Over the past few years, there has been increased interest in evaluating the effect of lutein for optimizing immune functions. A large number of epidemiological studies support the notion that a high intake of lutein is associated with a reduced risk of coronary heart disease and certain types of cancer. The biological mechanisms for the protective effects of this carotenoid, including powerful modulation of functions and antioxidant properties, are only partially known. Although several nutrients and phytochemicals have been shown to modulate immune functions in humans, few studies have investigated the role of lutein consumption. No information is available as to whether lutein supplementation could be protective against oxidative stress. Therefore, the objective of the present study was to examine the effect of consuming different doses of lutein on oxidative stress in healthy subjects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants with a history of smoking, alcohol consumption, body mass index (BMI)≥30kg/m2, allergies, ocular diseases and participants taking vitamins or other food supplements containing lutein were excluded from the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oxidative Stress in Healthy Subjects

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

20mg Lutein

Dietary Supplement: 20mg Lutein; daily supplementation 12 week

Group Type ACTIVE_COMPARATOR

Lutein

Intervention Type DRUG

Dietary Supplement: 20mg,10mg, 0mg Lutein; daily supplementation 12 week

10mg Lutein

Dietary Supplement: 10mg Lutein; daily supplementation 12 week

Group Type ACTIVE_COMPARATOR

Lutein

Intervention Type DRUG

Dietary Supplement: 20mg,10mg, 0mg Lutein; daily supplementation 12 week

0mg Lutein

Dietary Supplement: 0mg Lutein; daily supplementation 12 week

Group Type PLACEBO_COMPARATOR

Lutein

Intervention Type DRUG

Dietary Supplement: 20mg,10mg, 0mg Lutein; daily supplementation 12 week

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lutein

Dietary Supplement: 20mg,10mg, 0mg Lutein; daily supplementation 12 week

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy adult subjects aged in the range of 20 to 80

Exclusion Criteria

* Participants with a history of smoking
* Alcohol consumption
* Body mass index (BMI)≥30kg/m2
* Allergies
* Ocular diseases or recent infections(within the last year) and participants taking vitamins or other food supplements containing lutein the previous 2 months.
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Xi'an Jiaotong University

OTHER

Sponsor Role collaborator

Peking University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Le MA

Xi'an Jiaotong University College of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Xi'an Jiaotong University College of Medicine

Xi'an, Shaanxi, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

le ma, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Le MA, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CNS-06094

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bioavailability of Astaxanthin Formulations
NCT03443882 UNKNOWN EARLY_PHASE1